The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors Proceeds will be used to support the advancement of multiple first-in-class ...
Arkuda is backed by leading investors including Atlas Venture, Cormorant Asset Management, Pfizer Ventures, abrdn plc, Mission BioCapital, Johnson & Johnson (through its corporate venture capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback